COMPASS Pathways plc (CMPS): יחס שווי שוק לרווח וקצב צמיחה

Can the scientific potential of COMPASS Pathways plc (CMPS) drive a breakthrough? A comparison of P/E and growth rates provides the answer, with the indicator value standing at 0.00. A team of top psychologists supports the brand's humanitarian mission. The company is currently in a stage of large-scale testing without revenue, directing capital into laboratory monitoring. The flat line of the chart confirms the asset is undervalued relative to its expansion prospects.

The PEG ratio compares the market value of earnings to their growth rate, enabling the identification of undervalued assets when the value is below one. Analyzing the adjusted P/E relative to growth rates helps balance speculative risk, considering that for COMPASS Pathways plc (CMPS), the high logistics costs of specialized psychedelics and strict government control over supplies directly impact the business scaling rates.